RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Matrix Remodeling-Associated Protein 8 as a Novel Indicator Contributing to Glioma Immune Response by Regulating Ferroptosis.
Matrix Remodeling-Associated Protein 8 as a Novel Indicator Contributing to Glioma Immune Response by Regulating Ferroptosis.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
胶质瘤是一种高度恶性的脑肿瘤,生存率低。迫切需要新的生物标志物作为胶质瘤的早期指示物。在本研究中,我们通过GEO和TCGA数据库中胶质瘤的数据集,识别并验证了与预后相关的差异表达基因。铁死亡是一种新认识的细胞死亡过程,在癌症生物学中发挥重要作用。使用Pearson相关系数发现与铁死亡相关性最高的预后相关基因。基质重塑相关蛋白8(MXRA8)被鉴定为一种可能参与铁死亡的新型预后指标。与正常脑组织相比,MXRA8在胶质瘤中的表达显著升高,且MXRA8表达增加与不良生存相关。
此外,体外分析表明,敲低MXRA8抑制了T98G和U251细胞的细胞活力,并增加了胶质瘤细胞对替莫唑胺的敏感性。我们进一步观察到,MXRA8下调提高了细胞内亚铁离子和脂质过氧化水平,伴随NCOA4上调和FTH1抑制。
此外,共表达分析显示,GO术语和KEGG通路主要富集于免疫相关通路,如中性粒细胞相关免疫、适应性免疫应答和细胞因子结合。通过ssGSEA算法和TISIDB数据库,免疫学分析显示MXRA8与多种免疫浸润细胞显著相关,包括NK细胞、巨噬细胞和中性粒细胞。
同时,MXRA8还与趋化因子和多种免疫抑制分子相关,如TGF-β1、IL-10、PD-L1和CTLA4。我们还发现MXRA8与免疫浸润评分呈正相关,免疫评分较高的患者总生存期较差。
此外,IHC染色显示MXRA8与巨噬细胞标志物CSF1R高度正相关。胶质瘤细胞与M2巨噬细胞的共培养模型显示,MXRA8敲低的胶质瘤细胞减轻了M2巨噬细胞的浸润,而MXRA8导致的M2巨噬细胞浸润减少可被Fer-1处理所逆转。这些结果表明MXRA8促进胶质瘤进展,并突出了MXRA8在胶质瘤铁死亡和免疫微环境中的关键作用。因此,MXRA8可能作为胶质瘤的新型预后标志物和治疗靶点。
Glioma is a highly malignant brain tumor with a poor survival rate. Novel biomarkers that act as prompt indicators of glioma are urgently needed. In this study, we identified and validated prognosis-related differentially expressed genes by datasets of glioma in the GEO and TCGA databases. Ferroptosis is a newly recognized process of cell death playing a vital role in cancer biology.
Pearson correlation coefficient were used to discovery the prognosis-related genes which have the highest correlation with ferroptosis. Matrix remodeling-associated protein 8 (MXRA8) was identified as a novel prognosis indicator which may be involved in ferroptosis. The expression of MXRA8 was significantly higher in glioma compared with normal brain tissue, and increased expression of MXRA8 was associated with unfavorable survivals.
Furthermore, in vitro analysis showed that knockdown of MXRA8 inhibited the cell viability in T98G and U251 cells and increased the sensitivity of glioma cells to temozolomide.
We further observed that downregulation of MXRA8 elevated the levels of intracellular ferrous iron and lipid peroxidation, accompanied by upregulation of NCOA4 and suppression of FTH1.
Moreover, co-expression analyses showed that GO term and KEGG pathways were mainly enriched in immunity-related pathways, such as neutrophil-related immunity, adaptive immune response, and cytokine binding. Through ssGSEA algorithm and TISIDB database, immunological analyses showed that MXRA8 was significantly correlated with various immune infiltration cells including NK cells, macrophages, and neutrophils. Meanwhile, MXRA8 was also associated with chemokines and multiple immunoinhibitory molecules, such as TGF-β1, IL-10, PD-L1, and CTLA4.
We also found that MXRA8 was positively associated with immune infiltration score, and patients with higher immune score underwent worse overall survivals.
Moreover, IHC staining indicated a highly positive correlation of MXRA8 with a macrophage marker CSF1R. The co-cultured models of glioma cells and M2 macrophages showed MXRA8 knockdown glioma cells alleviated the infiltration of M2 macrophage, while the reduced M2 macrophage infiltration generated by MXRA8 could be rescued by Fer-1 treatment. These results suggest that MXRA8 promotes glioma progression and highlight the pivotal role of MXRA8 in ferroptosis and immune microenvironment of glioma.
Therefore, MXRA8 may serve as a novel prognostic marker and therapeutic target for glioma.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。